Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Market price (% of par)
-
98.57%
-
Total 13F principal
-
$21,445,940
-
Principal change
-
+$265,000
-
Total reported market value
-
$40,691,968
-
Number of holders
-
11
-
Value change
-
+$258,846
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q2 2025
As of 30 Jun 2025,
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 was held by
11 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$21,445,940
in principal (par value) of the bond.
The largest 10 bondholders included
Pentwater Capital Management LP, PenderFund Capital Management Ltd., DeepCurrents Investment Group LLC, Jefferies Financial Group Inc., OAKTREE CAPITAL MANAGEMENT LP, Russell Investments Group, Ltd., ZAZOVE ASSOCIATES LLC, ZAZOVE ASSOCIATES LLC, DCF Advisers, LLC, and Context Capital Management, LLC.
This page lists
11
institutional bondholders reporting positions
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.